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Plasmodium falciparum: A Comparison of the Activity of 
Pfs230-Specific Antibodies in an Assay of Transmission-Blocking 
Immunity and Specific Competition ELISAs
W. R o e f f e n ,  P. J. A. B e c k e r s ,  K. T e e l e n ,  T . L e n s e n ,  R. W. S a u e r w e i n ,
J. H. E. TH. M e u w is s e n , a n d  W. E lin g
University o f  Nijmegen, Department o f  Medical Microbiology, P.O. Box 9101,
6500 HB Nijmegen, The Netherlands
R o e ffe n ,  W., Beckers, P. J. A., T ee len , K., L ensen , T., S a u e rw e in ,  R. W., M eu­
w issen, J. H. E. TH., an d  E lin g , W. 1995. Plasmodium falciparum: A comparison of the 
activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and 
specific competition ELISAs. Experimental Parasitology 80, 15-26. The activity o f mono­
clonal antibodies (mAbs) that specifically recognize the Plasmodium falciparum  sexual 
stage-specific protein Pfs230 was analyzed. All mAbs reacted with the surface of extracel­
lular sexual forms of the parasite in a suspension immunofluorescence antibody reaction and 
precipitated the Pfs230 protein from an NP-40 extract of surface radioiodinated macroga­
metes/zygotes. Only mAb that bound complement blocked transmission, whereas mAb that 
did not bind complement but competed with the complement-binding mAb for binding to the 
same epitope did not block transmission. These mAbs were used to develop Pfs230-specific 
competition ELISAs to analyze epitope diversity and to analyze the binding characteristics 
of anti-Pfs230 antibodies in human serum. Transmission-blocking (TB) antibodies in test/ 
field sera competed in the competition ELISA for binding with epitope-specific, labeled 
mAbs against Pfs230. At least five different epitope regions could be defined with the 
competition ELISAs. All 46 sera from gametocyte carriers immunoprecipitated the Pfs230 
molecule, while 19 of these sera blocked transmission in the bioassay. Five of the trans- 
mission-blocking and one of the nonblocking sera competed with monoclonal antibodies. A 
method comparison analysis was used to determine agreement between reactions in a com­
petitive ELISA and the TB activity examined in the bioassay. The index of agreement k 
between outcomes of the bioassay and ELISA was fair to poor (k =  0,25) but since its range 
includes values below 0 the relation between the data obtained by the bioassay and the 
competition ELISA can be explained by chance alone. The serological data did not reveal 
a correlation between immunoprécipitation of Pfs230 and TB activity. © 1995 Academic
Press, Inc.
I n d e x  D e s c r i p t o r s  a n d  A b b r e v i a t i o n s : Plasmodium falciparum; Malaria; Antibod­
ies; Competition ELISA; Transmission-blocking (TB); Plasmodium falciparum  surface pro­
tein (Pfs); Kilodalton (kDa); Fast Protein Liquid Chromatography (FPLC); Sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); Horseradish peroxidase (HRPO);
Tissue culture medium-199 (M l99) containing 0.1% glucose (M199-G); Room temperature 
(RT); Immunofluorescence microscopy with dried parasites as the antigen (IFA); Suspen­
sion IFA with live parasites as the antigen (SIFA); Fetal calf serum (FCS); Triton X-114 
(TX-114); Phenylmethylsulfonyl fluoride (PMSF); Aqueous phase (AP); Detergent phase 
(DP); Monoclonal antibody (mAb); Immunoglobulin (Ig): Fluorescein isolhiocyanate 
(FITC); HRPO-labeled rabbit a-mouse Ig (RAMPO); Optical density (OD); Immunoprécip­
itation (IP); Phosphate-buffered saline (PBS); Poly-L-lysine (PLL); Nonidet-P40 (NP-40);
Pfs230 competition ELISA (C230-EL1SA); Polyvinyl difluoride (PVDF).
I n t r o d u c t i o n
Malaria is transmitted from man to mos­
quito through gametocytes that develop in 
the blood of infected patients and are taken
up by the female mosquito when taking a 
bloodmeal. Gametocytes o f Plasmodium  
falciparum synthesize molecules of appar­
ent Mv on SDS-PAGE of 230 and 48/45 kDa 
(Pfs230 and Pfs48/45), which remain ex­
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posed on the surface of macrogametes and 
zygotes (Vermeulen et a l  1985«, 1986; Ku­
mar and Carter 1984). These molecules and 
a surface molecule of apparent M r of 25 
kDa (Pfs25) presented on developing zy­
gotes, retort cells, and ookinetes are the 
targets of mAbs some of which can block 
the subsequent differentiation of the sexual 
stages in the mosquito; this is defined as 
tran sm issio n -b lo ck in g  (TB) im m unity  
(Rener et a i  1983; Vermeulen et al. 1985«; 
Quakyi et al. 1987). TB antibodies are 
found in sera from people exposed to natu­
ral malaria and are— at least in part—asso­
ciated with immunoglobulin reactivity of 
these sera (Meuwissen et a i  1985; Mulder 
et a i  1993).
The conventional bioassay of TB activity 
is based on development of oocysts in mos­
quitoes after membrane feeding of gameto- 
cytes as described by Vermeulen et a i  
(1985«). It is a costly, labor-intensive as­
say, thus limiting the number of sera that 
can be tested. Development of a serological 
test predicting TB activity would greatly 
simplify the study of the significance of TB 
immunity. A number of studies indicate 
that antibody responses to epitopes of 
Pfs48/45 and Pfs230 are part of the response 
observed after several malaria episodes 
(Graves et al. 1988, 1990; Carter et al. 1989) 
and that some epitope regions are con­
served in many isolates (Foo et a i  1991). 
Immunoprécipitation with sera from people 
living in endemic areas precipitated radio- 
iodinated Pfs48/45 and Pfs230. In Papua 
New Guinea sera there was a good correla­
tion between TB activity and antibody re­
sponse to I25I~labeIed Pfs23Q, although no 
such correlation was found for Pfs48/45 an­
tibody reactivity  (G raves et al. 1988), 
Among the Sri Lanka sera no correlation 
was found between TB activity and the 
presence of antibodies to Pfs230 as de­
tected by immunoprécipitation of radioiodi- 
nated gamete proteins (Premawansa et al. 
1994).
In the present study a Pfs230-enriched
fraction from gametocytes was used for the 
production of anti-Pfs230 mAbs and devel­
opment of ELIS As. Competition ELIS As 
using different H R PO labeled mAbs, im- 
munoprecipitation, and W estern blot anal­
ysis were developed to characterize anti­
body reactiv ity  to various epitopes of 
Pfs230 in sera collected from gametocyte 
carriers . R eactivity  in the competition 
ELISA was compared to TB activity in the 
bioassay to analyze a possible predictive 
value of the competition ELISA  for TB ac­
tivity.
M a t e r ia l s  a n d  M e t h o d s
Parasites
Mature gametocytes of P .fa lcipam m  (isolate NF54) 
were produced in an automated large-scale culture 
system as described by Ponnudurai et al. (1982). Ma­
ture gametocytes were isolated at 37°C to prevent ga* 
metocyte activation as follows. Parasite culture was 
diluted 10-fold in M199 containing 0.1%  glucose 
(M199-G). After centrifugation for 15 min at 2O0G# the 
pelleted parasites were resuspended  in M199-G, 
loaded on a cushion of 18% Nycodenz, and centri­
fuged for 30 min at 5000# as described by Vermeulen 
et al, (1985«). The purified gametocytes were used (a] 
directly, for SIFA, (b) allowed to exflagellate to collecl 
macrogametes and zygotes for use as dried antigen in 
IFA, or (c) stored at ~70°C until used for extraction of 
Pfs230,
Macrogametes and zygotes were purified and used 
for surface radioiodination and immunoprecipitation 
as described by Vermeulen et a l  (1985#).
The Pfs230-Enriched Aqueous Phase  (AP)
Extract o f Gametocytes
Gametocytes suspended in 140 mM  N H 4C1 in 10 
m M  Tris/HCl (pH 7.4) were incubated on ice for 5 min 
to  lyse the erythrocyte membrane and parasites were 
pelleted by centrifugation (5 min, 16,000# at RT). Par­
asites were solubilized in 2% TX-114 in a 10 mM  Tris/ 
HC1 buffer (pH 7.4) containing 1 mM  PM SF at 4°C as 
described by Bordier (1981) and Kumar (1985). The 
AP and detergent phase (DP) obtained by this method 
were collected separately. The AP (Pfs23Q-enriched 
antigen) was dialyzed against 0.1 M  N H 4H C 0 3 and 
freeze-dried in aliquots equivalent to 2 x 107 gameto­
cytes.
Sera
Field sera, A total of 46 sera was collected from 
gametocyte carriers (aged between 6 and 36 years)
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recruited at a dispensary in Yaounde, Cameroon 
(Tchuinkam et al. 1993).
Positive control. Serum of a Dutch expatriate who 
worked in an endemic malaria area in Tanzania for 
more than 30 years (Stl). This serum was positive in 
all tests used.
Negative control. A panel of individual serum sam­
ples and a pooled sample of these sera (N56) were 
obtained from Dutch bloodbank donor volunteers, 
with no previous history of malaria.
Complement. Freshly obtained AB blood from 
Dutch bloodbank donors with no previous malaria ex­
posure was allowed to clot at room temperature for 1 
h and aliquots of the pooled serum were stored at 
-70°C until required. Freshly thawed samples were 
used as a source of complement.
Rabbit a-PLL serum. Rabbit anti-poly-L-lysine se­
rum was a gift from Dr. P. Rotmans, Laboratory of 
Parasitology, University of Leiden, The Netherlands.
Monoclonal Antibodies
The Pfs230-specific mAb 28F1 has been described 
by Vermeulen et al, (1985a, 1986). MAb 18F25 was 
produced and characterized as described by Ver­
meulen et ai. (1985a). MAbs 11E3, 12F10, 4H2, 12B3, 
and 14G8, all reacting with Pfs230, were a kind gift of 
Dr. R. Carter, Division of Biological Sciences, Edin­
burgh, England.
For the preparation of new mAbs freshly isolated 
aqueous phase from a TX-114 extraction (AP), equiv­
alent to 2 x 107 parasites in 50 jj.1 PBS, was emulsified 
in 50 jxl Freund’s complete adjuvant and injected in- 
traperitoneally in BALB/c mice. The mice were 
boosted twice with AP in Freund’s incomplete adju­
vant. Serum samples were tested by ELISA (see be­
low) and on Western blots with gametocyte proteins. 
Mice were killed 3 days after the last boost, spleen 
cells were fused with myeloma cells (P3/X63-Ag8.653), 
and suitable hybridomas were selected as described in 
more detail by Vermeulen et al. (1985a). The super- 
nates were screened by antibody reactivity in (a) an 
IFA using air-dried sexual stage parasites, (b) SIFA 
and (c) a one-site ELISA using AP as antigen (see 
below). Positive wells were cloned twice by limiting 
dilution and further tested on Western blots and by 
immunoprécipitation (see below). Selected clones 
were further expanded and ascitic fluids were pro­
duced. TB activity of ascitic fluid or its purified IgG 
preparations was determined in the bioassay (see be­
low).
Purification o f  Monoclonal Antibodies
Ascitic fluid was defatted with silicon dioxide 
(Sigma S-5631) as described by Neoh et a i  (1986), the 
immunoglobulin (Ig)-containing supernate was dia-
lyzed against 0 .1 M  NH4H C 0 3 and freeze-dried in bot­
tles o r IgG was fu r th e r  purified using a sem i- 
automated FPLC system (Pharmacia) equipped with a 
Protein A column (Pharmacia). The IgG preparation 
was mixed with buffer A (0.1 M  Tris/HCl +  1.0 M 
Na2S 0 4, pH 8.0) loaded on the column at a flow rate of 
1 ml/min and washed with buffer A for 8 min. Subse­
quently, buffer B (0.1 M  glycine/HCl, pH 2.5) was 
added to obtain a gradient of 5 to 50% B in 15 min 
followed by elution with 100% B for 5 min. The IgG- 
containing fractions were pooled, dialyzed against 0.1 
M  NH4H C 0 3, and aliquots stored freeze-dried in bot­
tles. All IgG subclasses including IgGl can be recov­
ered under these conditions.
Surface Immunofluorescence Assay
SIFA was performed with live macrogametes and 
zygotes. All incubations were done at 50 pd FCS for 15 
min (for activation and exflagellation). A 50-jjlI anti­
body test sample was added and incubated for 15 min. 
After washing with PBS, the cells were incubated with 
50 ( j lI  FITC-conjugated goat anti-mouse IgG (Cappel 
55493) diluted in PBS with 0.05% Evans blue for 10 
min. After two PBS washings, the cells were examined 
under a cover glass with vaseline-coated edges on a 
Leitz Ortholux fluorescence microscope (500 x magni­
fication).
Transmission-Blocking Assay
A bioassay, using membrane feeders to feed A. 
gambiae mosquitoes, was used to determine TB ca­
pacity of serum samples (Vermeulen et aL 1985a; Pon- 
nudurai et al. 1987» 1989). All samples were separately 
tested in the presence of active or inactivated comple­
ment; all measurements were repeated at least once. 
Field sera were diluted 3-fold and mAbs or IgG prep­
aration of the sera 10-fold with negative human serum. 
Twenty mosquitoes per feeder were dissected 7 days 
after feeding, the number of oocysts on the stomach 
wall was counted and William’s mean (adjusted geo­
m etric  m ean (GM)) o o cy s t n u m b e r  c a lc u la te d  
(William, 1937). An experiment was considered suc­
cessful if at least 90% of the mosquitoes of the controls 
carried oocysts. The adjusted GM was used to deter­
mine the reduction activity (R) according to the equa­
tion
R  =  T[ x 100%,
* C
where Tx is the geometric mean for the test feeder and 
Tc is the geometric mean of three controls.
Because of assay variation only values over 85%
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were considered to be a positive transmission-blocking 
result.
Immunoprecipitation
Macrogametes and zygotes were surface radioiodi- 
nated by catalyzed iodination (isotope I25iodine), sol­
ubilized by NP-40, and the extract was used for indi­
rect immunoprecipitation as described by Vermeulen 
et al. (1985a),
Labeling of the mAbs with HRPO
Labeling of FPLC-purified mAb with HRPO was 
performed using the periodate method with an input 
molar HRPO/IgG ratio of 4 according to Wilson and 
Nakane (1978). The labels were dialyzed against PBS, 
supplemented with thimerosal (0.01%) and FCS (1%), 
and the samples freeze-dried in bottles and stored 
at 4°C.
Enzyme-Linked Immunosorbent Assays
I, Detection of Pfs230. (a) Microtiter plates were 
coated with PLL, washed with PBS, and incubated 
with serial dilutions of AP in PBS. Subsequently, free 
PLL binding sites were blocked by incubation with 0.2 
mg/ml rabbit a-poly-L-lysine Ig in PBS for 30 min. Fol­
lowing three washes with PBS, the wells were incu­
bated with 50 fil HRPO-labeled anti~Pfs230 mAb (2 
jxg/ml) for 2 hr, After a washing step, plates were in­
cubated with 60 jil TMB (0.25 mAi 3 ,3 \5 ,5 '-  
tetramelhylbenzidine, 0.7 mM  H20 2, 0,1 M  sodiumac- 
etate, pH 5.5) substrate solution for 20 min. The en­
zyme reaction was stopped by adding 60 |xl 4 N  H2S 0 4 
and the optical density (QD) was determined on an 
ELISA reader at 450 nm (Titertek Multiskan MCC/
340).
(b) Two-site ELISAs were carried out as described 
by Vermeulen et a i  (19856), Zavala et ai. (1983), and 
Carter et al. (1985). Microtiter plates were coated with 
50 pi of anti-.Pfs230 mAb (10 jxg/ml) in PBS for 30 min. 
Plates were washed three times with PBS and satu­
rated with 5% FCS in PBS. After incubation with AP 
extract the wells were incubated with HRPO-labeled 
anti-Pfs230 mAbs, substrate and the absorbance read 
at 450 nm as above.
IL Competition ELISAs. Pfs23Q was captured from 
AP extract in microtiter plates as described above un­
der la or lb. After three washes with PBS, wells were 
incubated with a mixture of 30 fil test sample and 30 jxl 
HRPO-labeled anti-Pfs23G mAb for 2 hr. Competition 
ELISAs were carried out using serial twofold dilutions 
of unlabeled anti-Pfs230 mAbs (ranging from 31 to 
4000 ng/ml) or human sera (ranging from 1/10 to 1/640) 
made up in PBS containing 0.1% FCS. The plates were 
washed, incubated with substrate, and the absorbance 
was read at 450 nm as above.
All incubations were carried out at room t e x ­
ture. The competition titer is defined as the dilute 
the test serum that results in the same OD reading
* ■
the  (competition negative) control serum. Sera »ill 
titer >  1/20 are considered positive.
Comparison o f  the TB Assay and 
Competition ELISA fo r  Sera
The results of competition ELISAs and the bioa$<- 
were compared by a statistical test on  agreement^- 
kappa as the index of observed agreement (Landisr 
Koch 1977; Altman 1991). The index kappa (kH: 
calculated from the observed and expected (ctai, 
distribution) frequencies on the diagonal of the 2 r 
table of outcomes of the bioassay and ELISA 
Table IV). The approximate standard error ofjck
o p , . =  f t .  (1 -  fi>)
SE(k) y n d - P ' ) 2 ’
where P 0 is observed proportional agreement and Pri 
the expected proportional agreement by chance. 1  
approximate 95% confidence interval is given by k:
1.96 SE(k), The index of agreement k has a maxims: 
1,00 when agreement is perfect, a value of zero itic 
cates no agreement better than chance. Negatived 
ues indicate disagreement. The guideline by Atom: 
(1991) was used to determine the strength of agw 
ment.
RESULTS
Detection and preservation o f  Pfs230k 
gam etocyte extracts. Pfs230 was found t( 
be exclusively present in the AP of the TX- 
114 ex trac t which also contained tract 
amounts of other protein molecules such a* 
27, 16, 48/45 kDa as detected by specific 
ELISA s and SDS-PAGE analysis (data not 
shown).
Immunoreactivity of Pfs230 in the freshlv 
prepared AP with mAbs 18F25 and 28F1 as 
determined by one- or two-site ELISA or 
on W estern blot decreased rapidly during 
further processing and storage. After two 
cycles of freeze-thawing of a freshly pre­
pared AP, only 20% immunoreactivity was
left with mAb 18F25 and no immu noreac­
tivity at all with mAb 28F1. Pfs230 detec­
tion did not change using protein staining 
on SD S-PA G E gels (data not shown). In 
addition, immunoreactivity of Pfs230 was
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lost during freeze-drying in PBS (increased 
gait co n cen tra tio n s  generated  during 
freeze-drying). Exposure to lOx concen­
trated PBS or 1 M  NH4HCO3 solution led 
to  an instantaneous loss of immunoreactiv- 
ity in the one-site ELISA. Immune reactiv­
ity was preserved when AP was dialyzed 
against 0.1 M N H 4H C 0 3, freeze-dried, and 
stored at 4°C, Pfs230 immunoreactivity ap­
peared to be stable for 6 to 8 weeks when 
stored in vacuo or under N2 gas and only 2 
weeks when stored under air or in solution.
Immunoreactivity o f  anti-Pfs230 mAbs 
and epitope mapping. All mAbs including 
the newly developed 63F2A2 (IgG2a), 
63F3C8, and 63F6D7 (both IgGl) as well as 
18F25, 28F1, 4H2, 12B3, and 14G8 (all 
IgGl) and 11E3 and 12F10 (both IgG2a) re­
acted specifically with air-dried gameto- 
cytes and the surface of freshly prepared 
live intact macrogametes and zygotes. All 
above mentioned mAbs precipitated Pfs230 
of 125I surface radioiodinated gametes (data 
not shown). On Western blots of NP-40 ex­
tracts of nonlabeled gametocytes, mAbs 
63F2A2, 63F6D7, 12F10, 18F25, and 11E3 
recognized proteins of apparent Mr 230 and 
260 kDa under nonreducing conditions. The 
other mAbs (63F3C8, 14G8, 4H2, 12B3,
and 28F1) showed no reactivity on W estern 
blot (see Table I).
C heckerboard titra tion s with various 
concentrations of labeled mAbs and AP 
were performed to establish optimal condi­
tions for Pfs230 detection. Such concentra­
tions of antigen and HRPO-labeled mAb 
were chosen so that maximal reduction of 
the OD was obtained when small amounts 
of competing antibody were included in the 
test. Optimal conditions for the competition 
ELISA were considered to be present with 
>60% of maximal binding of HRPO-mAb 
and an OD reading of >1 .0 . For mAbs 
63F2A2 (0.3 n.g/ml) and 63F6D7 (0.5 ^g/ml) 
equal concentrations of labeled mAb and 
the corresponding nonlabeled mAb at the 
50% com petition value was found. The 
HRPO-labeling method did not decrease 
the affinity of most mAbs. Only with mAbs 
28F1 (1.0 versus 0.1 |JLg/ml) and 63F3C8 (2.5 
versus 0.25 (xg/ml) was considerably less of 
the nonlabeled, corresponding mAb needed 
for 50% competition, suggesting that the 
immunoreactivity of these mAbs was sub­
stantially reduced after labeling.
The epitope specificity of each mAb was 
determined by (a) using different capture 
and labeled mAbs in two-site ELISAs and
TABLE I
Epitope Recognition of Anti-Pfs230 mAbs in the Two-Site ELISA
Pfs230
capture
antibody Blot IgG
HRPO-labeled second mAb
18F25 11E3 63F6D7 63F2A2 12F10 63F3C8 28F1
\a 18F25 + 1 — — + + + + +
11E3 + 2a — — + + + +
2 63F6D7 + 1 + + — — — + +
63F2A2 + 2a + + — — — + +
12F10 2a — — — — — — —
3 63F3C8 — 1 + + + + + — +
4H2 — 1 + nd + + — +
12B3 — 1 + nd + + + — +
4 28F1 — + + + + — + —
5 14G8 — 1 + + + + + 4-
Note. ( + ) Positive reaction; ( - )  no reaction; nd, not done; blot, immunoreaction on a Western blot; IgG, 
immunoglobulin subclass. 
a Epitope region.
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(b) competition between labeled mAbs and 
various unlabeled mAbs in one-site compe­
tition ELISAs. None of the labeled mAbs 
bound to Pfs230 when captured by the cor­
responding nonlabeled mAbs. The results 
with both systems (Tables I and II) suggest 
the presence of five distinct epitopes or 
epitope regions with two exceptions; (a) 
when 12F10 was used to capture Pfs230 no 
reaction with any of the labeled mAbs 
could be found, whereas 12F10 reacted 
with Pfs230 captured by several other 
mAbs. This may indicate that coated mAb 
12F10 cannot capture Pfs230. (b) Competi­
tion between mAbs was independent of the 
use of the mAb in labeled or unlabeled 
form, except for 63F2A2. In the one-site 
ELISA, 63F2A2 com peted with labeled 
28F1, but labeled 63F2A2 did not compete 
with unlabeled 28F1. This may indicate that 
63F2A2 and 28F1 react w ith the same 
epitope but with a considerable difference 
in affinity. A tentative map of the five 
epitope regions is given in Fig. 1.
Transmission-blocking activity o f  mAbs. 
Ascitic fluid and/or purified IgG from the 
hybridomas were included in the transmis- 
sion-blocking feeder assay in the presence 
of either active or inactivated complement. 
Figure 1 shows that 5 |xg of mAbs 11E3,
12F10, and 63F2A2 (all IgG2a) blocked 
transmission more than 99%, but only in 
the presence of complement. MAbs 18F25, 
63F6D7, 63F3C8, 4H2, 12B3, 28F1, and 
14G8 (all being IgGl) did not reduce trans­
m ission irrespective of the presence of 
complement. Thus, epitope analysis and 
transmission-blocking experim ents show 
that both blocking and nonblocking mAbs 
reacted with the same epitope and also 
compete for binding to that epitope. Trans­
mission-blocking activity correlates with 
the p resence  of the com plem ent fixing 
IgG2a isotypes which are only available for 
two epitopes (see Fig. 1).
Transmission-blocking activity in human 
field sera , Forty-six sera from gametocyte 
carriers, heat inactivated at 56°C for 30 
min, were tested in feeding experiments in 
the presence of active and inactivated com­
plement. Nineteen (41.3%) of these 46 sera 
consistently blocked transm ission in the 
presence of complement. Twelve of the 19 
sera with a TB activity were retested in the 
bioassay both in the presence of either ac­
tive or inactivated complement. None of 
these 12 field sera showed a complement- 
dependent transmission-blocking activity 
(data not shown).
Pfs230-associa ted  TB a c tiv ity .  All 46
TABLE II
Competition of mAbs in the One-Site Pfs230 ELISA
Competition
mAb
HRPO-labeled mAb
18F25 I1E3 63F6D7 63F2A2 12F10 63F3C8 28F1
r 18F25 + -t- — — — —
11E3 + + — — — — —
2 63F6D7 — — + + + — —
63F2A2 — + 4* + — +
12F10 — + + + — —
3 63F3CS — — — — — + —
4H2 — — — — — + —
12B3 — — — — — + —
4 28F1 — — — — — — +
5 14G8 — — — — — _ —
Note. ( + ) Competition between labeled and nonlabeled mAbs; ( - )  no competition between labeled and 
nonlabeled mAbs. 
a Epitope region.
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These 46 sera were further analyzed in a 
two-site competition ELISA  with 18F25 as 
capture mAb and HRPO-63F2A2 as label. 
Figure 2 shows competition by a serial di­
luted positive (S tl) in comparison to a neg­
ative serum (N56). The negative serum did 
not compete with HRPO-63F2A2 for bind­
ing to Pfs23Q. The overall interassay vari­
able in this test (six times tested in dupli­
cate) has an average deviation of the mean 
OD at each dilution step of 0.12 (21%). The 
overall intraassay variation resulted in an 
average deviation of the mean. Seven dif­
ferent mAbs reactive to the five epitopes/ 
regions of Pfs230 described above, includ­
ing the complement-dependent TB mAbs 
11E3 and 63F2A2, were labeled with HRPO 
to investigate their competition with anti­
bodies in serum samples of gametocyte car­
riers in the two-site competition ELISA . 
Table III shows that competition-positive 
human field sera (6 of 46) competed with all 
labe led  m A bs, i .e . ,  w ith all ep ito p es / 
regions available, with no exception either 
in the com petition-positive  or negative 
sera. N o significant differentiation in anti­
body responses to the d ifferent Pfs230 
epitopes was found. Five of these six sera 
blocked transmission. Serum 41 (see Table 
III), the only nonblocking serum, reduced 
sera of gametocyte carriers precipitated a transm ission in a com plem ent-dependent 
molecule of apparent Mr on SDS-PAGE of 
230 kDa from NP-40 extracts of 125I surface The correlation between the TB activity 
radioiodinated gametes and reacted with (positive ^85% , negative <85%) and the 
molecules of apparent Mr of 230 and 260 
kDa on a Western blot of NP-40 extracts of
Q(63F3C8
TB- (1) 
bh
Fig .  1. Epitope regions of Pfs230 identified with a 
series of monoclonal antibodies tested in a one-site 
competition ELISA. MAbs are either effective at 
blocking transmission of infection to m osquitoes 
(TB + ) or ineffective (T B -) .  Competitive interactions 
in the ELISA are indicated as (—>), no competition 
(—>||) or not tested (—>?). The isotype of the mAb is 
given in parenthesis. Reaction with Pfs230 on Western 
blot is given as positive (bl + ) and negative (b l - ) .
way.
Pfs230 competition ELISA is depicted in 
Table IV. Five (26%) serum samples were 
nonlabeled gametocytes under nonreducing positive in the TB assay and in the compe- 
conditions (data not shown). These results tition ELISA, 14 (30%) were negative in the
also showed that the antibodies present in 
the sera of the gametocyte carriers to n 5I- 
labeled Pfs230 precip itated  a variab le  
amount of the Pfs230 band. Due to varia­
tion of the 125I labeling of various batches of 
parasites used for these analysis our tech-
competition ELISA  but positive in the TB 
assay, and 26 (56%) were negative in both 
tests. The index of agreement between the 
outcomes of bioassay and the competition 
E L ISA  is k  = 0.25, 95% confidence inter­
val -0 .0 6 , +  0.56. The index indicates (Alt-
nique only permitted a sem iquantitative man, 1991) that agreement is fair to poor
analysis and no correlation was found be­
tween antibody reactivity to l25I-labeled 
Pfs230 and TB activity,
and the negative value in the confidence in­
terval indicates that agreement can be ex­
plained by chance. The ELISA  outcom es
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OD at 450nm
1 /  Dilution of human sera
Fig. 2. Optical densities a t 450 nm with increasing serum dilutions in a two-site competition ELISA. 
MAb 18F25 was used to capture the Pfs230 molecule from the aqueous phase and HRPO-63F2A2 for 
competition with a positive (Stl) and negative (N56) human serum.
show a relative specificity of 96% (26 o f 27) 
and a relative sensitivity of 26% (5 of 19),
D iscussion
A panel of monoclonal antibodies belong­
ing to different IgG subclasses was ana­
lyzed for Pfs230 binding and TB activity. 
All mAbs reacted in the indirect IFA with
the surface of macrogametes and zygotes.o: 
P . falciparum  and all immunoprecipitatec 
Pfs230 from NP-40 extracts o f surface ra 
dioiodinated macrogametes and zygotes 
On W estern blots prepared from gameto 
cy te  ex tracts, only mAbs 18F25, 11E3. 
63F2A2, 63F6D7, and 12F10 recognize 
Pfs230 under nonreducing conditions. It
TABLE III
Percentage Transmission-Reducing Activity (R) in the Presence of Active (AC) or Inactivated (IC) 
Complement and the Epitope-Specific Compeition Titer of Five Pfs230 Epitope Regions in Positive Field
Sera from 46 P. falciparum  Gacnetocyte Carriers
HRPO-labeled competing mAb
18F25 I1E3 63F2A2 63F6D7 63F3C8 28F1 14GS
Serum AC IC (1) (1) (2) (2) (3) (4) (5)
4 99 ndrt 160 320 80 160 80 160 640
19 100 98 80 40 40 80 40 80 320
38 90 nd 80 40 40 160 80 80 nd
39 96 97 80 80 40 160 40 80 320
41 73 18 40 80 40 B0 40 40 160
48 89 80 80 80 40 160 40 40 160
N56* 0 0 -------- — -------- --------- — --------- —
Stlc 100 100 320 160 160 640 80 160 nd
( —) Titer <1/40; () epitope region; 
nd, not done.
b N56, A pool from Dutch blood donors with no history of malaria. 
c Stl * A positive control serum which blocks transmission.
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TABLE IV
Agreement between Transmission-Blocking Activity 
(TB Assay) and Pfs230 Competition ELISA 
(C230-ELISA) of 46 Sera from Gametocyte
Carriers, Cameroon
TB assay
Number of C230-ELISA 
serum samples
Positive Negative Total
5=85% 5 14 19
<85% 1 26 27
Total 6 40 46
Note. Relative specificity = 26 of 27, or 96.3%; rel­
ative sensitivity = 5 of 19, or 26.3%; observed pro­
portional agreement (5 + 26)/46 = 0.67; chance pro­
portional agreement (6/46 x 19/46) + (40/46 x 27/46) 
=  0.57; observed minus chance agreement (0.67-0.57) 
=  0.11; maximum possible agreement beyond chance 
level (1-0.57) = 0.43; agreement quotient ( k ),  0.11/ 
0.43 = 0.25.
addition, on SDS-PAGE a protein of appar­
ent Mr of 260 kDa is also recognized on 
blots. This difference between results ob­
tained with immunoprecipitation and West­
ern blot analysis has been described before 
(Quakyi et al. 1987) and is best explained by 
the intracellular localization of a higher Mr 
precursor of Pfs230. MAbs can also be sub­
divided by their ability to block transmis­
sion, i.e., all IgGl mAbs were negative and
IgG2a mAbs (11E3, 63F2A2, and 12F10)
blocked transmission in a complement-de- 
pendent reaction. Complement-dependent 
lysis of macrogametes and zygotes in vitro 
by Pfs230 mAbs has been described by 
Quakyi et al. (1987) and has also been found 
in the P. gallinaceum system (Kaushal et 
al. 1983).
These mAbs were used for the develop­
ment of a number of different ELISAs in 
order to construct an epitope map of Pfs230 
(Fig. 1), to determine the presence of anti- 
Pfs230 antibodies in field sera and to corre­
late presence of anti-Pfs230 antibodies in 
field sera with TB activity of these sera as 
observed in the bioassay.
The Pfs230 antigen used in these ELISAs
was prepared by Triton TX-114 (gameto­
cyte extraction and phase separation as de­
scribed  by B ord ier (1981) and K um ar 
(1985). It appeared that immunoreactivity 
of Pfs230 in these extracts was lost upon 
storage in PBS solution, after f re e z e -  
thawing, or exposure to high-salt concen­
tration. The use of aqueous solutions con­
taining a volatile buffer for freeze-drying 
and storage in vacuo prevented loss of im­
munoreactivity for periods of 2 months. 
Loss of immunoreactivity of Pfs230 after 
exposure to high-salt concentration  has 
been observed before (Kumar and Wizel,
1992). The loss of immunoreactivity in so­
lution suggests tha t oxidative changes 
could be in v o lv ed  in c o n fo rm a tio n a l 
changes of Pfs230. However, storage of AP 
in the presence of either vitamin E or glu- 
tathion did not prevent loss of immunore­
activity (data not shown).
One-site ELISA s could not be devel­
oped by direct coating of Pfs230 to the 
plates, but was realized by coating on a 
precoat of poly-L-lysine or Pfs230-specific 
mAb. The positive charge of poly-L-lysine 
most probably enables binding with the 
glutamate-rich Pfs23G (Williamson et al.
1993).
This panel of mAbs enabled the recogni­
tion of five different epitope regions on the 
Pfs230 m o lecu le , each e p ito p e  being  
present only once. Monoclonal antibodies 
allocated to two epitope regions (here des­
ignated 1 and 2) were able to react on a 
Western blot. All mAbs of the complement 
fixing IgG2a subclass blocked transm is­
sion, whereas none of the m Abs of the com­
plement nonfixing IgGl subclass did. Thus, 
both TB-positive and negative antibodies 
can bind to the same epitope and compete 
w ith one a n o th e r  for b ind ing  to  th a t  
epitope. MAbs to the three other regions 
(designated 3 to 5) did not block transm is­
sion but these were all of the IgGl subclass.
In a panel of sera from gametocyte carri­
ers from Cameroon all 46 sera immunopre- 
cipitated Pfs230, and 19 sera exhibited TB
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activity. Sera were classified with respect 
to their capacity to im m unoprecipitate 
Pfs230 by a semiquantitative analysis of au­
toradiograms; compared to the results of 
the TB bioassay this revealed no correla­
tion {P value -  0.396). None of 12 sera 
showing TB activity needed the presence of 
complement for this activity. M ore sera 
need to be tested before definite conclu­
sions can be drawn on the role of comple­
ment in TB activity of human field sera.
Six sera of these gametocyte carriers 
from Cameroon were positive in the com­
petition ELISA and this was independent 
of the epitope region analyzed, indicating 
that there was no epitope restriction. Five 
of these com petition-positive sera  also 
blocked transmission in the bioassay, but 
14 of the 19 blockers were negative in the 
competition assays.
To compare the outcomes of TB assay 
and ELISA a statistical test for comparison 
of proportions or association is not consid­
ered appropriate. Besides sensitivity and 
specificity a measure of agreement is re­
quired rather than association. The index of 
agreement k measures the amount of agree­
ment beyond chance and can be used for 
the correlation analysis. In gametocyte car­
riers the amount of agreement was fair to 
poor but since the confidence interval con­
tains zero, this implies that the agreement 
can be explained by chance.
In summary, the Cameroon field sera ex­
hibit (a) absence of complement depen­
dency of TB activity, (b) reactivity with all 
available epitopes o f Pfs230 analyzed so 
far, and (c) no correlation between either 
the Pfs230 competition ELISA or immuno­
précipitation of Pfs230 from NP-40 gameto­
cyte extracts and TB activity as observed in 
the b ioassay . This ra ises the question  
whether under field conditions TB activity 
is Pfs230 mediated.
Our results are in contrast to results ob­
tained in a series of Papua New Guinea 
sera, where Graves et a i  (1988) observed a 
correlation between immunoprécipitation
of Pfs230 and reduction of infectivity to 
mosquitoes. In our hands all the Cameroon 
sera precipitated Pfs230 and a semiquanti* 
tative analysis on autoradiograms revealec 
no correlation with TB activity. One aspect 
is the difference in study populations. A 
parallel study analyzing TB activity and an­
tibody reactivity against Pfs230 as deter­
mined by im m unoprecipitation in a Sn 
Lanka population failed to show this corre­
lation (Premawansa et al. 1994). Our data 
do not exclude the possibility that Pfs230 
mediated TB activity might be present h 
field sera which are complement indepeiv 
dent. Another important question is to find 
out whether Pfs230-mediated TB activity is 
always complement dependent.
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